Alzheimer's disease is associated with removal of the synaptic protein ADAM10

May 8, 2013

Alzheimer's disease is characterized by the accumulation of neurotoxic β-amyloid peptide (A-beta). ADAM10, a protein that resides in the neural synapses, has previously been shown to prevent the formation of A-beta.

In this issue of the Journal of Clinical Investigation, Monica Di Luca and colleagues at the University of Milan in Milan, Italy, report that ADAM10 is removed from synapses through association with the protein AP2.

Strikingly, the association between ADAM10 and AP2 was increased in homogenates from Alzheimer's disease (AD) patients compared to healthy controls.

was shown to influence the level and activity of ADAM10 in synapses and its association with AP2.

These studies identify pathological mechanisms associated with AD that control the localization of proteins at the synapse.

Explore further: New findings contradict dominant theory in Alzheimer's disease

More information: Endocytosis of synaptic ADAM10 in neuronal plasticity and Alzheimer's disease J Clin Invest. doi:10.1172/JCI65401

Related Stories

Recommended for you

Immune cells may protect against Alzheimer's

May 19, 2016

Clusters of immune cells in the brain previously associated with Alzheimer's actually protect against the disease by containing the spread of damaging amyloid plaques, a new Yale University School of Medicine study shows.

Brain imaging links Alzheimer's decline to tau protein

May 11, 2016

A buildup of plaque and dysfunctional proteins in the brain are hallmarks of Alzheimer's disease. While much Alzheimer's research has focused on accumulation of the protein amyloid beta, researchers have begun to pay closer ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.